ViaCord
Pioneering Cord Blood and Genomic Services to Empower Families
Robert Gendron, VP and General Manager
Cord Blood and Tissue Bank
Cord Blood and Tissue Bank is a specialized biomedical repository that collects, processes, cryogenically preserves, and stores umbilical cord blood and tissue stem cells. These banks enable regenerative medicine, transplantation, and therapeutic research, offering future clinical applications for hematologic disorders, genetic diseases, and advanced cellular therapies in personalized healthcare ecosystems.
Solutions
ViaCord has been a trusted name in the cord blood banking space for over 30 years, offering families a unique opportunity to safeguard their children’s future health.
State of Industry
Cord Blood Banking Reimagined: A Decentralized Blueprint for Personalized Medicine
Modern healthcare is undergoing a significant transformation toward patient-centricity, accessibility, and technology, redefining all aspects, from routine examinations to intricate clinical trials, with the individual at the focal point. Within this evolving framework, the practice of cord blood biobanking—the retrieval and cryopreservation of potent stem cells from the umbilical cord at parturition—is transcending its conventional, centralized limitations. Drawing inspiration from the impetus of Decentralized Clinical Trials (DCTs), the cord blood sector is spearheading a more adaptable, remote, and community-centric paradigm that aims to broaden access and enhance viability for the next generation of regenerative medicine.
Deep Dive
Cord Blood and Tissue Banking for Earlier Family Health Decisions
Cord blood and tissue banking now sits at the crossroads of newborn care, regenerative medicine, family health planning, and long-term laboratory stewardship. For executives evaluating a banking partner, the decision goes far beyond simply storing a biological sample at birth. The real question is whether a provider can support families during a narrow and often stressful collection window, preserve future clinical possibilities, and help turn stored biological material into meaningful health insight over time. The value of the service depends on trust before delivery, precision during collection, and clear communication long after storage begins.
Leadership Perspective
University of Pennsylvania Health System
Cell Therapies: Here comes the next wave!
Robert Richards, Corporate Director of the Center for Cell Therapy and Transplant, Penn Medicine
Robb Richards has over 20 years of experience in oncology, first with a private practice in Southern New Jersey and more recently the University of Pennsylvania Health System. He has served in different roles throughout his healthcare career: IT Manager for the Center for Cancer and Hematologic Disease in Cherry Hill, Division Chief Operating Officer of Regional Cancer Care Associates (RCCA) in Cherry Hill, New Jersey, and RCCA corporate VP and Chief Information Officer. He unofficially joined Penn’s Cell Therapy and Transplant program (CTT) in 2016 and was the lead in overseeing the operationalizing/implementation of CAR T cell therapy for commercial use. Currently, he is the Corporate Director of The Center for Cell Therapy and Transplant program at Penn Medicine, overseeing commercial and research work and its expansion into community hospitals within the Penn system. He also assists other disease groups within the organization as they are onboarding gene therapies.
Cord Blood and Tissue Bank Info
Q1
What Do Top Cord Blood and Tissue Banks Provide for Families?
Top Cord Blood and Tissue Banks collect, process and preserve newborn stem cells obtained from umbilical cord blood and cord tissue after childbirth. These stem cells may later support medical treatments, regenerative medicine research or family-directed therapies. Cord blood contains hematopoietic stem cells associated with blood and immune system regeneration, while cord tissue contains mesenchymal stem cells that are widely studied in regenerative medicine. Many cord blood and tissue bank providers also offer genetic screening and long-term cryogenic storage services for families planning future healthcare options.
Q2
What Services Are Included in Cord Blood and Tissue Banking?
Services offered by Top Cord Blood and Tissue Banks typically include collection kits, laboratory processing, stem cell isolation, cryogenic preservation and long-term storage management. Some cord blood and tissue banking companies also provide newborn genetic testing, whole genome sequencing and hereditary health insight services. Families may choose private storage for personal use or explore public donation programs depending on eligibility and regional availability. Many cord blood and tissue bank providers additionally support sibling donor programs and clinical research participation tied to regenerative medicine and transplant therapies.
Q3
Why Is Demand Increasing for Cord Blood and Tissue Banks?
Demand for Top Cord Blood and Tissue Banks continues to grow because families are becoming more aware of stem cell preservation and personalized healthcare planning. Advances in regenerative medicine, stem cell therapy research and genetic screening have expanded interest in newborn biological storage. Cord blood stem cells are already used in treatments for dozens of blood, immune and metabolic disorders, while cord tissue research continues advancing in areas linked to inflammation, tissue repair and neurological conditions. Rising interest in preventive healthcare and family-focused medical planning has also contributed to broader adoption of cord blood and tissue banking services.
Q4
How Are Top Cord Blood and Tissue Banks Evaluated?
Families and healthcare professionals often evaluate Top Cord Blood and Tissue Banks based on laboratory accreditation, storage standards and clinical reliability. Important considerations include FDA registration, AABB accreditation, processing technology, storage infrastructure and long-term preservation methods. Parents may also review transplant release history, genetic testing capabilities and customer support services before selecting a provider. Many cord blood and tissue banking companies are assessed on how effectively they maintain sample viability, ensure regulatory compliance and support future therapeutic access.
Q5
What Value Do Cord Blood and Tissue Banking Services Offer?
Top Cord Blood and Tissue Banks provide families with access to preserved stem cells that may support future medical treatments or participation in emerging regenerative medicine therapies. For some families, banking stem cells offers reassurance when there is a known hereditary condition or elevated risk of blood-related diseases. Cord blood and tissue banking services may also support faster treatment access because preserved cells are immediately available for compatibility evaluation if needed. The category’s broader value lies in preserving biological resources during childbirth that cannot be collected again later in life.
Q6
How Is Innovation Changing Cord Blood and Tissue Banking?
Innovation continues shaping Top Cord Blood and Tissue Banks through improvements in stem cell processing, cryogenic storage and genomic analysis technologies. Many cord blood and tissue bank providers are integrating advanced genetic testing, digital health platforms and expanded stem cell preservation techniques into their services. Research in regenerative medicine is also increasing interest in how preserved stem cells may support future therapies beyond traditional transplant applications. As precision medicine and cellular therapies evolve, cord blood and tissue banking companies are expected to play a larger role in personalized healthcare and long-term family wellness planning.
